Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IPO Flurry In 2004? Aspirants Stress Profitability, Economic Upturn As Key

This article was originally published in The Gray Sheet

Executive Summary

Increased access to group purchasing contracts - and a subsequent surge in market share - may provide pulse oximeter developer Masimo with the fiscal confidence to pursue an initial public offering during the second half of the year
Advertisement

Related Content

Novacept Sellers Benefited By Running IPO, M&A Processes Simultaneously
Novacept Sellers Benefited By Running IPO, M&A Processes Simultaneously
Cautious Venture Capital Commands Medtech Start-Ups To Think Long-Term
Cautious Venture Capital Commands Medtech Start-Ups To Think Long-Term
Happy Hunting: Tyco Nellcor, Masimo Find Dual-Source Contracts Abet Sales
Happy Hunting: Tyco Nellcor, Masimo Find Dual-Source Contracts Abet Sales
Happy Hunting: Tyco Nellcor, Masimo Find Dual-Source Contracts Abet Sales
Eye Care Firms Ride New Products, Overseas Growth To Fuel Stocks In 2004
Financings In Brief
Advertisement
UsernamePublicRestriction

Register

MT019713

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel